FDA.reportPublic FDA data

Hepatitis C virus total antibody IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of total antibodies to the Hepatitis C virus in a clinical specimen.
GUDID devices
15
Last updated
2026-09-14 22:40:04

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00380740199272AlinityAbbott GmbH06T79102026-09-04
00380740203108AlinityABBOTT LABORATORIES04W56152025-07-21
00380740203115AlinityABBOTT LABORATORIES04W56252025-07-21
04015630936946PreciControl Anti-HCVRoche Diagnostics GmbH032903791902023-01-23
07613336182970PreciControl Release Anti-HCVRoche Diagnostics GmbH093666521902025-02-18
07613336183144PreciControl Anti-HCVRoche Diagnostics GmbH032903791622025-02-18
00380740177676AlinityAbbott GmbH04W56202024-01-17
00380740177683AlinityAbbott GmbH04W56242024-01-17
10758750001156VITROSORTHO CLINICAL DIAGNOSTICS68014212020-04-01
00380740130640AlinityAbbott GmbH08P05102019-10-11
00380740163525AlinityAbbott GmbH06P04202019-09-28
00380740163549AlinityAbbott GmbH06P04242019-09-28
00630414473178ADVIA Centaur® Systems HCV QCSiemens Healthcare Diagnostics Inc.103090622014-09-24
00630414597874Atellicaâ„¢ IM aHCV QCSiemens Healthcare Diagnostics Inc.109954572018-10-16
00380740001407ARCHITECTAbbott GmbH1L79-102014-11-18